Results 41 to 50 of about 699,373 (191)

Management of Primary Pterygium with Intralesional Bevacizumab (AVASTIN) Injection

open access: yesPakistan Armed Forces Medical Journal, 2023
Objective: To determine the management of primary Pterygium with intralesional Bevacizumab (AVASTIN) Injection. Study Design: Quasi-Experimental Study Place and Duration of Study: Armed Forces Institute of Ophthalmology, Rawalpindi Pakistan, from ...
Irum Mahmood   +5 more
doaj   +1 more source

Efficiency and safety of subconjunctival injection of anti-VEGF agent - bevacizumab - in treating dry eye [PDF]

open access: yes, 2015
Purpose: Dry eye is a chronic inflammatory ocular surface disease with high prevalence. The current therapies for dry eye remain to be unspecific and notcomprehensive.
Wang, Wei   +5 more
core   +1 more source

Comparison of the inhibitory effect of different doses of subconjunctival bevacizumab application in an experimental model of corneal neovascularization [PDF]

open access: yesInternational Journal of Ophthalmology, 2018
AIM: To evaluate the inhibitory effect of subconjunctival bevacizumab as single- and multiple-dose application, and compare their effects on corneal neovascularization in a rat model.
Burak Ulas   +2 more
doaj   +1 more source

Postoperative adjunctive bevacizumab versus placebo in primary trabeculectomy surgery for glaucoma [PDF]

open access: yesInternational Journal of Ophthalmology, 2019
AIM: To compare the effectiveness of postoperative adjunctive use of subconjunctival bevacizumab in altering the outcome of primary trabeculectomy in terms of sustained lowering of intraocular pressure (IOP) and reduction of postoperative bleb ...
Sana’ Muhsen   +4 more
doaj   +1 more source

Bevacizumab plus Irinotecan-Based Regimens in the Treatment of Metastatic Colorectal Cancer [PDF]

open access: yes, 2010
Objectives: Bevacizumab is a monoclonal antibody that directly inhibits vascular endothelial growth factor, a key regulator of angiogenesis. Bevacizumab significantly improves progression-free and/or overall survival in metastatic colorectal cancer in ...
Volker Heinemann   +3 more
core   +1 more source

Microenvironment‐Responsive Drug Delivery Systems for Ocular Surface Diseases: Mechanisms, Applications, and Translational Challenges

open access: yesSmall Science, Volume 6, Issue 8, August 2026.
Microenvironment‐responsive drug delivery systems overcome ocular physiological barriers by responding to temperature, pH, ions, reactive oxygen species, and enzymes. This review bridges material design, performance evaluation, and clinical translation, offering actionable insights for treating dry eye disease, infectious keratitis, and corneal ...
Jiamin Liu   +3 more
wiley   +1 more source

Resolution of Refractory Corneal Neovascularization with Subconjunctival Bevacizumab

open access: yesCase Reports in Ophthalmology, 2020
Corneal neovascularization (CNV) has a variety of causes and threatens corneal clarity, thus optimal visual acuity. Conventional medical management includes topical steroids and matrix metalloproteinase inhibitors like doxycycline.
Anna Krystyna Britton   +1 more
doaj   +1 more source

Bevacizumab as adjuvant therapy in the management of pterygium: a systematic review and Meta-analysis [PDF]

open access: yesInternational Journal of Ophthalmology, 2017
AIM: To evaluate the clinical effect of bevacizumab in pterygium treatment. METHODS: A systematic review and quantitative Meta-analysis was performed. PubMed, EMBASE, Web of Science and Cochrane database were searched for eligible literatures published ...
Jian Liu   +7 more
doaj   +1 more source

The outcome of preoperative subconjunctival bevacizumab injection in pterygium surgery

open access: yesJournal of the Egyptian Ophthalmological Society, 2014
Objective The aim of this study was to evaluate the safety and the efficacy of subconjunctival injection of bevacizumab (Avastin) for the management of primary and recurrent pterygia and to estimate the recurrent rate of pterygia after surgery. Patients and methods The study included 60 eyes of 60 patients (45 male and 15 female), with a mean age of 41
AhmedS Mohamed   +2 more
openaire   +1 more source

Mechanisms controlling the effects of bevacizumab (avastin) on the inhibition of early but not late formed corneal neovascularization.

open access: yesPLoS ONE, 2014
PurposeTo evaluate the effects and underlying mechanisms of early and late subconjunctival injection of bevacizumab on the inhibition of corneal neovascularization (NV).MethodsCorneal NV was induced by closed eye contact lens wear followed by a silk ...
Wei-Li Chen   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy